Scores of people globally are marking Fragile X Awareness Month in July with activities aimed at calling attention to the…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The ABLE Employment Flexibility Act and better workplace opportunities for people with disabilities are among priorities for this year’s…
To help find new fragile X treatments, the Robert & Ardis James Foundation has presented the Fraxa Research…
Many COVID-19 clinics are large, crowded, and on the boisterous side, which can be overwhelming for people with fragile…
The McQuade Center for Strategic Research and Development (MSRD) will collaborate with Sentinel Oncology for the…
A Rush University Medical Center scientist will use a $4 million “cooperative agreement” from the Centers for Disease Control…
From posting yard signs to swapping out exterior lighting, people across the U.S. are poised to mark Fragile X…
At its first virtual investor event, biotech company Centogene set a bold mission: to cure 100 rare diseases…
To help patient advocacy leaders and their partners better understand how global health statistics codes — known as ICD codes…
Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual…